News
FTC says Shkreli is flouting lifetime pharma ban
The FTC and several US states have accused Martin Shkreli of violating a lifetime order preventing him from involvement in the pharma industry.
News
Brent Saunders ejects from Bausch + Lomb once again
Brent Saunders' second stint as chief executive of eye care company Bausch + Lomb has come to an end.
News
Aicuris acquisition delivers new drug for Asahi Kasei
Asahi Kasei's $920m takeover of Germany's Aicuris in April has paid off with FDA approval for the herpes simplex virus drug at the heart of the deal.
News
Viatris builds in pain relief with $1.65bn Pacira purchase
As it waits for an FDA decision on one non-opioid pain drug, Viatris has its eye on two more, via a takeover bid for Pacira BioSciences.
News
Pfizer's Tukysa greenlit for earlier use in breast cancer
Pfizer gets FDA approval for maintenance use of its oral HER2 inhibitor Tukysa in breast cancer, which it hopes will unlock renewed sales growth.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
